Not available
Quote | Novelion Therapeutics Inc. (NASDAQ:NVLN)
Last: | $ |
---|---|
Change Percent: | -3.34% |
Open: | $0.60 |
Close: | $0.68 |
High: | $0.683 |
Low: | $0.54 |
Volume: | 238,397 |
Last Trade Date Time: | 10/08/2019 04:49:15 pm |
News | Novelion Therapeutics Inc. (NASDAQ:NVLN)
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that on October 7, 2019 the Nasdaq Office of General Counsel notified the Company that the Nasd...
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) today announced that it has filed its notice of meeting and definitive proxy statement with the applicable...
Message Board Posts | Novelion Therapeutics Inc. (NASDAQ:NVLN)
Subject | By | Source | When |
---|---|---|---|
Shareholders post | TRUSTUNITS1000000 | investorshub | 01/16/2023 4:38:42 PM |
Shareholders post | TRUSTUNITS1000000 | investorshub | 09/15/2022 10:59:10 AM |
Shareholders post and how much a share of liquidation | TRUSTUNITS1000000 | investorshub | 06/04/2022 6:20:58 PM |
Share holders post | TRUSTUNITS1000000 | investorshub | 04/29/2022 8:41:55 AM |
Shareholders post | TRUSTUNITS1000000 | investorshub | 03/18/2022 1:42:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Novelion Therapeutics Inc. Company Name:
NVLN Stock Symbol:
NASDAQ Market:
Novelion Therapeutics Inc. Website:
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that on October 7, 2019 the Nasdaq Office of General Counsel notified the Company that the Nasd...
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) today announced that it has filed its notice of meeting and definitive proxy statement with the applicable...
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that, further to its press release dated September 11, 2019, the acquisition by Amryt Pharma Pl...